ProQR Therapeutics N.V. buy Citigroup Inc.
Start price
10.03.25
/
50%
€1.87
Target price
10.03.26
€3.68
Performance (%)
0.11%
Price
23.12.25
€1.76
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for ProQR Therapeutics N.V. is nearly unchanged. This prediction currently runs until 10.03.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| ProQR Therapeutics N.V. | 1.790% | 1.790% |
| iShares Core DAX® | 0.224% | 2.457% |
| iShares Nasdaq 100 | 0.371% | -0.320% |
| iShares Nikkei 225® | 0.972% | -0.829% |
| iShares S&P 500 | 0.417% | -0.157% |
Comments by Citigroup_Inc_ for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating. They now have a $4.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.78
19.04.24
19.04.24
€1.88
19.04.25
19.04.25
-36.85%
20.04.25
20.04.25
